MENUNews Archive
Date: 09/24/2020
Researchers at the Medicine C.S Mott Children’s Hospital and the U-M Rogel Cancer Center have been breaking new ground in understanding and treating childhood brain cancers, including some of the most serious and aggressive types of tumors.
Date: 09/23/2020
Postdoctoral training is to bench scientists what residency programs are to medical students — a period of mentored apprenticeship to bridge the gap between one’s student years and an independent career.
Date: 09/20/2020
A new inhibitor designed to target what’s been called an “undruggable” genetic mutation showed promising activity against advanced cancers with this mutation.
Date: 09/18/2020
The new report from the American Association for Cancer Research (AACR) highlights the impact of cancer health disparities and calls for transformative research, collaboration and committed funding to ensure research-driven advances benefit everyone.
Date: 09/16/2020
A new $3.7 million grant, as part of the Beau Biden Cancer Moonshot Initiative, will support a clinical trial designed to test a personalized family genetic risk navigation support platform. The trial will be extended to all first- and second-degree relatives of 900 patients in Georgia and California in whom genetic testing identified a variant indicating an elevated hereditary cancer risk.
Date: 09/15/2020
A team of researchers from the Rogel Cancer Center have received a $2.9 million grant from the National Cancer Institute to look at how HPV behaves in patients with head and neck cancer and how that could help identify who might benefit from less-aggressive treatment.
Date: 09/09/2020
If cancer is a series of puzzles, a new study pieces together how several of those puzzles connect to form a bigger picture.
One major piece is the immune system and the question of why certain immune cells stop doing their job. Another piece involves how histones are altered within immune cells. A third piece is how a cell’s metabolism processes amino acids.
Date: 08/28/2020
Using a technique called single-cell RNA sequencing, a research team from U-M was able to show for the first time how individual cells within a single population of cancer cells respond differently to the DNA damage caused by chemotherapy.
Date: 08/26/2020
What is the connection between COVID-19 and cancer? Arul Chinnaiyan, M.D., Ph.D., has focused his entire career on cancer, identifying in 2005 a protein that plays a key role in the development of prostate cancer. It turns out it may also factor into how coronaviruses replicate.
Date: 08/24/2020
Rogel Cancer Center members have received grant funding for 10 projects related to COVID-19. Some are using their basic science acumen or public health perspective to better understand the virus and its implications. Others focus on the coronavirus’s impact on the care of people with cancer.